Zynex Past Earnings Performance

Past criteria checks 1/6

Zynex has been growing earnings at an average annual rate of 14.3%, while the Medical Equipment industry saw earnings growing at 13.6% annually. Revenues have been growing at an average rate of 33.6% per year. Zynex's return on equity is 21.1%, and it has net margins of 5.3%.

Key information

14.3%

Earnings growth rate

13.2%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate33.6%
Return on equity21.1%
Net Margin5.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Earnings Miss: Zynex, Inc. Missed EPS By 33% And Analysts Are Revising Their Forecasts

Mar 03
Earnings Miss: Zynex, Inc. Missed EPS By 33% And Analysts Are Revising Their Forecasts

Why Investors Shouldn't Be Surprised By Zynex, Inc.'s (NASDAQ:ZYXI) P/E

Jan 24
Why Investors Shouldn't Be Surprised By Zynex, Inc.'s (NASDAQ:ZYXI) P/E

Is Zynex (NASDAQ:ZYXI) Using Too Much Debt?

Aug 03
Is Zynex (NASDAQ:ZYXI) Using Too Much Debt?

Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 43%?

Mar 30
Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 43%?

Should You Be Adding Zynex (NASDAQ:ZYXI) To Your Watchlist Today?

Jan 23
Should You Be Adding Zynex (NASDAQ:ZYXI) To Your Watchlist Today?

Short Squeeze Candidate With Low PEG Ratio: Zynex

Oct 05

Zynex begins enrollment in blood loss detection trial for CM-1600 monitoring system

Sep 21

These 4 Measures Indicate That Zynex (NASDAQ:ZYXI) Is Using Debt Safely

Aug 02
These 4 Measures Indicate That Zynex (NASDAQ:ZYXI) Is Using Debt Safely

Zynex Cures The Pain Of Its Shareholders: Q2 Results

Aug 01

Zynex: Upside Looks Well Priced In, Efficiency Headwinds Remain

Jul 25

Is Zynex, Inc. (NASDAQ:ZYXI) Trading At A 46% Discount?

Jul 12
Is Zynex, Inc. (NASDAQ:ZYXI) Trading At A 46% Discount?

Zynex June and Q2 orders hit all-time high, re-affirms Q2 and FY22 guidance

Jul 11

Is It Time To Consider Buying Zynex, Inc. (NASDAQ:ZYXI)?

Apr 13
Is It Time To Consider Buying Zynex, Inc. (NASDAQ:ZYXI)?

Zynex (NASDAQ:ZYXI) Seems To Use Debt Quite Sensibly

Mar 23
Zynex (NASDAQ:ZYXI) Seems To Use Debt Quite Sensibly

Zynex: Letter Indicates UnitedHealthcare Is Terminating Contract - An Undisclosed Loss Accounting For 50%+ EBITDA

Feb 17

Zynex: Turnaround Nears Inevitable End - Largest Payor Cuts TENS Reimbursement, May Eliminate Earnings

Dec 10

Revenue & Expenses Breakdown
Beta

How Zynex makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:ZYXI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23184101360
30 Sep 23186161300
30 Jun 23177171220
31 Mar 23169171140
31 Dec 22158171040
30 Sep 2215018960
30 Jun 2214320890
31 Mar 2213719840
31 Dec 2113017810
30 Sep 2111610770
30 Jun 211015720
31 Mar 21895630
31 Dec 20809530
30 Sep 206910430
30 Jun 206011350
31 Mar 205210300
31 Dec 19459260
30 Sep 19419230
30 Jun 193710190
31 Mar 193410170
31 Dec 183210160
30 Sep 183110140
30 Jun 182910130
31 Mar 18279110
31 Dec 17237100
30 Sep 1718480
30 Jun 1715380
31 Mar 1713180
31 Dec 1613090
30 Sep 1613-1100
30 Jun 1612-2100
31 Mar 1612-290
31 Dec 1512-390
30 Sep 1511-190
30 Jun 1513-1100
31 Mar 1511-6110
31 Dec 1411-6110
30 Sep 1412-11130
30 Jun 1413-12150
31 Mar 1417-8210
31 Dec 1322-7210
30 Sep 1329-2210
30 Jun 1334-1211
31 Mar 13381171

Quality Earnings: ZYXI has a large one-off gain of $2.9M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: ZYXI's current net profit margins (5.3%) are lower than last year (10.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ZYXI's earnings have grown by 14.3% per year over the past 5 years.

Accelerating Growth: ZYXI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ZYXI had negative earnings growth (-42.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (8.7%).


Return on Equity

High ROE: Whilst ZYXI's Return on Equity (21.1%) is high, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.